Elite Wealth Management Inc. Buys Shares of 1,732 HCA Healthcare, Inc. $HCA

Elite Wealth Management Inc. purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 1,732 shares of the company’s stock, valued at approximately $820,000.

Other large investors have also recently made changes to their positions in the company. State Street Corp increased its stake in HCA Healthcare by 1.0% in the 4th quarter. State Street Corp now owns 7,566,643 shares of the company’s stock worth $3,532,563,000 after buying an additional 76,039 shares during the period. Capital World Investors grew its stake in HCA Healthcare by 0.8% in the 4th quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock worth $2,334,040,000 after acquiring an additional 40,086 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of HCA Healthcare by 0.4% during the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock valued at $1,702,738,000 after acquiring an additional 13,565 shares in the last quarter. Norges Bank bought a new position in HCA Healthcare in the fourth quarter worth approximately $1,262,513,000. Finally, Arrowstreet Capital Limited Partnership lifted its holdings in shares of HCA Healthcare by 11.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after buying an additional 245,887 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $389.74 on Tuesday. The business has a fifty day moving average price of $386.30 and a 200-day moving average price of $452.90. HCA Healthcare, Inc. has a 1-year low of $331.61 and a 1-year high of $556.52. The stock has a market capitalization of $86.46 billion, a price-to-earnings ratio of 13.05, a PEG ratio of 1.29 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping the consensus estimate of $7.56 by $0.03. The business had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter last year, the company earned $6.84 earnings per share. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 29.19 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be issued a dividend of $0.78 per share. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s payout ratio is 10.45%.

Key Stories Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Q2 results exceeded expectations. HCA reported adjusted earnings of $7.59 per share versus the $7.56 consensus estimate, while revenue rose 8.7% year over year to $20.23 billion, topping forecasts of $19.76 billion. The earnings beat and continued revenue growth are supporting investor sentiment. HCA Healthcare’s Q2 CY2026 sales top estimates
• Positive Sentiment: Analysts remain broadly constructive despite lower targets. Truist, Oppenheimer and KeyCorp cut their price targets but retained buy, outperform or overweight ratings. RBC also reaffirmed its outperform rating with a $435 target, indicating that analysts still see upside from current levels. HCA Healthcare Analysts Slash Their Forecasts After Q2 Results
• Neutral Sentiment: HCA declared a quarterly dividend of $0.78 per share. The dividend is payable September 30 to shareholders of record September 16 and carries an indicated yield of approximately 0.8%, providing modest shareholder income.
• Neutral Sentiment: Leadership change at two Tampa hospitals. HCA promoted a new chief executive officer for the facilities, a routine management update with limited immediate financial impact. HCA promotes new CEO of 2 Tampa hospitals
• Negative Sentiment: Uninsured Affordable Care Act patients are a concern. Nearly all of HCA’s ACA exchange patients reportedly lacked insurance coverage during the quarter, highlighting reimbursement and bad-debt risks that could weigh on margins and future earnings.
• Negative Sentiment: Multiple analysts reduced their forecasts after the earnings release. Barclays moved to equal weight with a $387 target, while Baird maintained a neutral rating and lowered its target to $393. The widespread target reductions suggest expectations for HCA’s future growth and profitability have moderated.
• Negative Sentiment: Mission Health compliance concerns remain unresolved. Reports of a third consecutive year of compliance issues add legal, regulatory and reputational risk for HCA. HCA Healthcare faces third straight year of Mission Health compliance concerns

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on HCA. Argus decreased their price objective on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a report on Monday, May 4th. Morgan Stanley lowered their price target on shares of HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a research report on Monday. Truist Financial reduced their price objective on shares of HCA Healthcare from $535.00 to $495.00 and set a “buy” rating for the company in a research note on Monday. Leerink Partners cut their price target on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Finally, Raymond James Financial set a $528.00 price objective on HCA Healthcare in a research report on Tuesday, July 7th. Fourteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $473.36.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.